Retinal dysfunctions in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 297-300

  Balogh, Zita ^a   Benedek, György ^b   Kéri, Szabolcs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Electroretinography; Retina; Schizophrenia; Vision

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; PHOTORECEPTOR; RETINA DISEASE; SCHIZOPHRENIA; SYMPTOM; VISUAL INFORMATION;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETINAL DISEASES; SCHIZOPHRENIA;

EID: 38349075405     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.024     Document Type: Article

References (25)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed (1994), American Psychiatric Association, Washington, DC
2. Bedwell J.S., Brown J.M., and Miller L.S. The magnocellular visual system and schizophrenia: what can the color red tell us?. Schizophr Res 63 (2003) 273-284
3. Butler P.D., and Javitt D.C. Early-stage visual processing deficits in schizophrenia. Curr Opin Psychiatry 18 (2005) 151-157
4. Chen Y., Levy D.L., Sheremata S., Nakayama K., Matthysse S., and Holzman P.S. Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia. Am J Psychiatry 160 (2003) 1795-1801
5. Chen Y., Levy D.L., Sheremata S., and Holzman P.S. Bipolar and schizophrenic patients differ in patterns of visual motion discrimination. Schizophr Res 88 (2006) 208-216
6. du Bois T.M., Deng C., and Huang X.F. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 878-888
7. Friedburg C., Allen C.P., Mason P.J., and Lamb T.D. Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram. J Physiol (Lond) 556 (2004) 819-834
8. Gerbaldo H., Thaker G., Tittel P.G., Layne-Gedge J., Moran M., and Demisch L. Abnormal electroretinography in schizophrenic patients with a history of sun gazing. Neuropsychobiology 25 (1992) 99-101
9. Green M.F., Nuechterlein K.H., Breitmeyer B., and Mintz J. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry 59 (2006) 446-451
10. Holopigian K., Clewner L., Seiple W., and Kupersmith M.J. The effects of dopamine blockade on the human flash electroretinogram. Doc Ophthalmol 86 (1994) 1-10
11. International Standardisation Committee. Standard for clinical electroretinography. Arch Ophthalmol 107 (1989) 816-819
12. Jeffrey B.G., Weisinger H.S., Neuringer M., and Mitchell D.C. The role of docosahexaenoic acid in retinal function. Lipids 36 (2001) 859-871
13. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
14. Kéri S., Kelemen O., Benedek G., and Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 31 (2001) 915-922
15. Kéri S., Antal A., Szekeres G., Benedek G., and Janka Z. Spatiotemporal visual processing in schizophrenia. J Neuropsychiatry Clin Neurosci 14 (2002) 190-196
16. Kéri S., Kelemen O., Benedek G., and Janka Z. Vernier threshold in patients with schizophrenia and in their unaffected siblings. Neuropsychology 18 (2004) 537-542
17. Kéri S., Benedek G., and Janka Z. Vernier threshold and the parallel visual pathways in bipolar disorder: a follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 86-91
18. Reid R.C. Vision. In: Squire L.R., Bloom F.E., McDonnell S.K., Roberts J.L., Spitzer N.C., and Zigmond M.J. (Eds). Fundamental Neuroscience (2003), Academic Press, London 727-754
19. Schechter G., Hock P., Rodgers K., Pfefferbaum A., Marmor M.F., and Berger P.A. Electroretinographic assessment in schizophrenia. Electroencephalogr Clin Neurophysiol Suppl 40 (1987) 746-751
20. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33
21. Slaghuis W.L. Contrast sensitivity for stationary and drifting spatial frequency gratings in positive- and negative-symptom schizophrenia. J Abnorm Psychol 107 (1998) 49-62
22. Warner R., Laugharne J., Peet M., Brown L., and Rogers N. Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: a pilot study. Biol Psychiatry 45 (1999) 1138-1142
23. Witkovsky P. Dopamine and retinal function. Doc Ophthalmol 108 (2004) 17-40
24. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667
25. Yeap S., Kelly S.P., Sehatpour P., Magno E., Javitt D.C., Garavan H., et al. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives. Arch Gen Psychiatry 63 (2006) 1180-1188